Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

XiVE S plus Impl D3.4/L9.5: medical device reports filed with FDA

2,032 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

2,032
device reports naming the brand
0% of all MAUDE reports · about 287 a year
185
reports, 12 months to August 2026
282 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

2,032 medical device reports received by FDA name the brand "XiVE S plus Impl D3.4/L9.5" (implant endosseous root-form); the manufacturer given most often on reports is Dentsply Implants Manufacturing; received from June 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

185 reports arrived in the 12 months to August 2026, down 34% from 282 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (40.2%), osseointegration problem (31.1%) and loss of osseointegration (20.8%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02448Sep 2021: 16Oct 2021: 20Nov 2021: 32Dec 2021: 292022Jan 2022: 38Feb 2022: 38Mar 2022: 28Apr 2022: 24May 2022: 31Jun 2022: 42Jul 2022: 40Aug 2022: 32Sep 2022: 33Oct 2022: 32Nov 2022: 34Dec 2022: 382023Jan 2023: 34Feb 2023: 47Mar 2023: 24Apr 2023: 40May 2023: 31Jun 2023: 43Jul 2023: 48Aug 2023: 21Sep 2023: 26Oct 2023: 28Nov 2023: 30Dec 2023: 252024Jan 2024: 32Feb 2024: 28Mar 2024: 23Apr 2024: 19May 2024: 20Jun 2024: 36Jul 2024: 17Aug 2024: 35Sep 2024: 28Oct 2024: 38Nov 2024: 20Dec 2024: 172025Jan 2025: 23Feb 2025: 18Mar 2025: 46Apr 2025: 2May 2025: 9Jun 2025: 20Jul 2025: 36Aug 2025: 25Sep 2025: 21Oct 2025: 20Nov 2025: 26Dec 2025: 112026Jan 2026: 24Feb 2026: 12Mar 2026: 13Apr 2026: 19May 2026: 6Jun 2026: 8Jul 2026: 9Aug 2026: 16

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02505002019: 4820192021: 50020212022: 41020222023: 39720232024: 31320242025: 25720252026: 1072026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,031
Malfunction0%1
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%2,032
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate81640.2%62.8%
Osseointegration problem63131.1%7.7%
Loss of osseointegration42220.8%22.4%
Fracturea broken bone1648.1%1.6%
Malposition of device20.1%0.1%
Off-label use20.1%0%
Loosening of implant not related to bone-ingrowth10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant2,02999.9%
Inflammationinflammation22210.9%
Osteolysis1507.4%
Pocket erosion1185.8%
Deformity/ disfigurement40.2%
Implant pain40.2%
Abscessa collection of pus20.1%
Inadequate osseointegration20.1%
Laceration(s)20.1%
Painpain, site not specified20.1%
Osteopenia/ osteoporosis10%
Taste disorder10%
Wound dehiscencea wound reopened10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureXiVE S plus Impl D3.4/L9.5Product code DZEAll MAUDE reports
Reports2,0323,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about XiVE S plus Impl D3.4/L9.5 reports

How many FDA reports name XiVE S plus Impl D3.4/L9.5?

2,032 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 185 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (40.2%), osseointegration problem (31.1%), loss of osseointegration (20.8%), fracture (8.1%) and malposition of device (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that XiVE S plus Impl D3.4/L9.5 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.